Location History:
- Givataím, IL (2004)
- Givataim, IL (1999 - 2008)
Company Filing History:
Years Active: 1999-2008
Title: Liora Cahalon: Innovator in Cytokine Regulation and Anti-Cancer Therapeutics
Introduction
Liora Cahalon is a prominent inventor based in Givataim, Israel. She has made significant contributions to the field of biotechnology, particularly in the regulation of cytokine activity and the development of anti-cancer therapeutic compounds. With a total of 5 patents to her name, her work has the potential to impact the treatment of various pathological processes.
Latest Patents
Cahalon's latest patents include innovative compositions for the regulation of cytokine activity. These substances, which comprise carboxylated and/or sulfated oligosaccharides in substantially purified form, are designed to either inhibit or augment the secretion of Tumor Necrosis Factor Alpha (TNF-α). The invention also encompasses pharmaceutical compositions aimed at preventing or treating conditions that involve active cytokine secretion. Additionally, her work on anti-cancer therapeutic compounds focuses on blocking the ability of cytokines and chemokines to promote the metastasis of malignant cells. These therapeutic compounds are primarily derived from heparin or heparan-sulfate and are designed to inhibit tumor cell migration.
Career Highlights
Cahalon's career is marked by her dedication to research and development in the field of biotechnology. She has been instrumental in advancing the understanding of cytokine regulation and its implications for cancer treatment. Her innovative approaches have garnered attention in the scientific community, leading to her recognition as a leading inventor in her field.
Collaborations
Throughout her career, Liora Cahalon has collaborated with esteemed colleagues, including Irun R Cohen and Ofer Lider. These collaborations have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Liora Cahalon's contributions to biotechnology, particularly in cytokine regulation and anti-cancer therapeutics, highlight her role as a significant inventor. Her work continues to pave the way for advancements in medical treatments and therapies.